[1]
P. Nygren, H. . Sørbye, P. . Österlund, and P. . Pfeiffer, “Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: An Acta Oncologica expert report”, AO, vol. 44, no. 3, pp. 203–217, May 2005.